Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-01-04 @ 8:58 AM
Study NCT ID:
NCT05060003
Status:
TERMINATED
Last Update Posted:
2024-02-20
First Post:
2021-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Sponsor:
Washington University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
202111158
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |